Cramer on BloggingStocks: Pelosi can't kill the health care sector


TheStreet.com's Jim Cramer says the Senate is filled with more-savvy politicians, and the upside for beaten-down names is huge.

Nancy Pelosi has now said her piece. The most unpopular Speaker of the House in the history of Wall Street has gotten her precious health care legislation through the House after ramming through a stimulus package that had far too little infrastructure and far too much pay raise for municipal and state workers, the most powerful interest group in the country.

But this time the Senate sees through it, and the politicians -- despite Pelosi's insistence that Tuesday's election went her way -- know better. There are pages after pages after pages in this bill that look threatening. But here's the rub: This bill's public option, the one that is supposed to be a killer to everything health care, should affect no more than 6 million people over a 10-year period, according to the Congressional Budget Office. In order to get 60 votes in the Senate, even that may prove to be too powerful an option.

Even better for the bulls, as we go into 2010 we will have seen the high-water mark of what Wall Street views as radicalism in Congress. That means you can see earnings per share increase and multiples expand for Humana (HUM) (Cramer's Take), WellPoint (WLP) (Cramer's Take), Aetna (AET) (Cramer's Take) and Cigna (CI) (Cramer's Take). You can buy Stryker (SYK) (Cramer's Take), which put up good numbers. You can expect that the highest-multiple pharma plays -- Celgene (CELG) (Cramer's Take), Abbott (ABT) (Cramer's Take) and Gilead (GILD) (Cramer's Take) -- can go higher.

You not only can stop fearing the sector, you can go overweight it -- not to mention that with Washington defanged, you can bet that the resistance upward will not be so stiff.

The House has spoken. Pelosi's spoken.

They are done talking.

The silence is golden.

Jim Cramer is co-founder and chairman of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. At the time of publication, Cramer was long Abbott and Gilead.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+33.0712,878.20
NASDAQ+2.092,904.08
S&P 500+2.721,347.05

Last updated: February 08, 2012: 01:00 AM

Hot Stocks

General Electric

19.18+0.13(+0.68)

Alcoa

10.67-0.065(-0.61)

Apple Inc

468.83+4.86(+1.05)

Google Inc 'A'

606.77-2.32(-0.38)

Bank of America

7.85-0.12(-1.51)

Wal-Mart Stores

61.69-0.19(-0.31)

Exxon Mobil Corp

86.34+0.59(+0.69)

Ford

12.88-0.08(-0.62)

Citigroup

33.07-0.23(-0.69)

IBM

193.35+0.53(+0.27)

Yahoo

15.83+0.01(+0.06)

Starbucks

48.41+0.12(+0.25)

Microsoft

30.35+0.15(+0.50)

Home Depot

45.46+0.26(+0.58)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines

    Page Loaded in 1328680855842 ms.